DeWeirdt, Peter C.
McGee, Abby V. http://orcid.org/0000-0001-9294-7039
Zheng, Fengyi http://orcid.org/0000-0003-4479-604X
Nwolah, Ifunanya
Hegde, Mudra http://orcid.org/0000-0003-4530-4633
Doench, John G. http://orcid.org/0000-0002-3707-9889
Article History
Received: 21 May 2022
Accepted: 30 August 2022
First Online: 6 September 2022
Competing interests
: J.G.D. consults for Microsoft Research, Abata Therapeutics, Servier, Maze Therapeutics, BioNTech, Sangamo, and Pfizer. J.G.D. consults for and has equity in Tango Therapeutics. J.G.D. serves as a paid scientific advisor to the Laboratory for Genomics Research, funded in part by GSK. J.G.D. receives funding support from the Functional Genomics Consortium: Abbvie, Bristol Myers Squibb, Janssen, Merck, and Vir Biotechnology. J.G.D.’s interests were reviewed and are managed by the Broad Institute in accordance with its conflict of interest policies. The remaining authors declare no competing interests.